Jagels M A, Ember J A, Travis J, Potempa J, Pike R, Hugli T E
Department of Immunology, Scripps Research Institute, La Jolla, California 92037, USA.
Adv Exp Med Biol. 1996;389:155-64. doi: 10.1007/978-1-4613-0335-0_19.
The anaerobic bacteria P. gingivalis has been implicated as a primary causative agent in adult periodontitis. Several proteinases are produced by this bacteria and it is suggested that they contribute to virulence and to local tissue injury resulting from infection by P. gingivalis. Collagenases and cysteine proteinases (i.e., the gingipains) have been characterized as the predominant vesicular enzymes produced by this bacterium. It has been shown that an arginine-specific cysteine proteinase from P. gingivalis, called gingipain-1 or Arg-gingipain, can selectively cleave complement components C3 and C5. In the case of C5, cleavage by Arg-gingipain results in the generation of C5a, a potent chemotactic factor for PMNs. Since these bacterial proteinases are capable of generating pro-inflammatory factors at sites of infection, we examined the possibility that gingipains or other proteinases from this bacterium might attack or destroy cell surface proteins, such as receptor molecules. Using an affinity-purified rabbit antibody raised against residues 9-29 of the C5a receptor (i.e., C5aR; CD88), the signal transmitting element for the pro-inflammatory mediator C5a, we demonstrated that the mixture of proteinases in P. gingivalis vesicles cleaves the C5a receptor on human neutrophils. This vesicular proteinase activity did not require cysteine activation which indicates that proteinases other than the gingipains may be responsible for cleavage of the C5aR molecule. in addition, the purified Lys-gingipain, but not Arg-gingipain, also cleaved C5aR on the human neutrophils. The N-terminal region of CaR (residues 9-29, PDYGHYDDKDTLDLNTPVDKT) was readily cleaved by chymotrypsin, but not by trypsin, despite the presence of potential trypsin (i.e., lysyl-X) cleavage sites. The specific sites of C5aR 9-29 peptide cleavage were determined by mass spectroscopy for both chymotrypsin and Lys-gingipain. These studies suggest that the proteolytic activity in the bacterial vesicles that is responsible for cleaving C5aR is primarily a non-tryptic proteinase, distance from either Arg- or Lys-gingipain. Consequently, there appear to be additional proteinase(s) in the vesicles that attacks the cell surface molecule C5aR which are not the same (i.e., Arg- and Lys-gingipain) as were shown to generate pro-inflammatory activity from complement components C3 and C5. Evidence that the proteinases which attack the inflammatory precursor molecules (i.e., C3 and C5) exhibit different specificities than those that attack receptors to these bioactive complement products makes a particularly interesting story of how this bacteria avoids major host defense mechanisms. It is well known that generation of pro-inflammatory factors such as C3a and C5a at extra-vascular sites can promote edema, leukocyte recruitment and cellular activation responses that could lead to the release of toxic oxygen products and to phagocytosis of the bacteria. Destruction of receptors to these cellular activating factors generated by bacterial proteinases may eliminate the ability of these (i.e., complement-derived) and other mediators to carry out their anti-bacterial actions and thereby limit the host's defense mechanisms in responses to the infecting bacteria. The concept of anti-bacterial responses (i.e., oxygen radical generation and phagocytosis) being effectively eliminated at the injury site, by bacterial proteinases acting at the cellular receptor level, has not been studied in detail. In this case, the situation is particularly unusual because, once the bacterial gingipains generate potent plasma-derived inflammatory factors that can enhance edema and deliver essential nutrients to the bactgeria, other bacterial proteinases may destsroy their cellular receptors. These receptors transmit the signal activation mechanisms in the infiltrating cells that elicit bacterial killing.(ABSTRACT TRUNCATED)
厌氧菌牙龈卟啉单胞菌被认为是成人牙周炎的主要致病因子。该细菌可产生多种蛋白酶,有人认为这些蛋白酶有助于牙龈卟啉单胞菌感染导致的毒性作用和局部组织损伤。胶原酶和半胱氨酸蛋白酶(即牙龈蛋白酶)已被确定为该细菌产生的主要囊泡酶。研究表明,牙龈卟啉单胞菌的一种精氨酸特异性半胱氨酸蛋白酶,称为牙龈蛋白酶-1或精氨酸牙龈蛋白酶,可选择性裂解补体成分C3和C5。就C5而言,精氨酸牙龈蛋白酶的裂解会产生C5a,这是一种对中性粒细胞有强大趋化作用的因子。由于这些细菌蛋白酶能够在感染部位产生促炎因子,我们研究了该细菌的牙龈蛋白酶或其他蛋白酶是否可能攻击或破坏细胞表面蛋白,如受体分子。我们使用针对C5a受体(即C5aR;CD88)9-29位残基产生的亲和纯化兔抗体,C5a是促炎介质C5a的信号传导元件,结果表明牙龈卟啉单胞菌囊泡中的蛋白酶混合物可裂解人中性粒细胞上的C5a受体。这种囊泡蛋白酶活性不需要半胱氨酸激活,这表明除牙龈蛋白酶外的其他蛋白酶可能负责C5aR分子的裂解。此外,纯化的赖氨酸牙龈蛋白酶而非精氨酸牙龈蛋白酶也可裂解人中性粒细胞上的C5aR。尽管存在潜在的胰蛋白酶(即赖氨酰-X)裂解位点,但C5aR的N端区域(9-29位残基,PDYGHYDDKDTLDLNTPVDKT)很容易被胰凝乳蛋白酶裂解,而不被胰蛋白酶裂解。通过质谱分析确定了胰凝乳蛋白酶和赖氨酸牙龈蛋白酶对C5aR 9-29肽的具体裂解位点。这些研究表明,负责裂解C5aR的细菌囊泡中的蛋白水解活性主要是一种非胰蛋白酶,与精氨酸或赖氨酸牙龈蛋白酶不同。因此,囊泡中似乎存在其他蛋白酶,它们攻击细胞表面分子C5aR,这些蛋白酶与那些能从补体成分C3和C5产生促炎活性的蛋白酶不同(即精氨酸和赖氨酸牙龈蛋白酶)。攻击炎症前体分子(即C3和C5)的蛋白酶与攻击这些生物活性补体产物受体的蛋白酶具有不同特异性,这一证据揭示了该细菌如何逃避主要宿主防御机制的有趣故事。众所周知,在血管外部位产生的促炎因子如C3a和C5a可促进水肿、白细胞募集和细胞激活反应,这可能导致有毒氧产物的释放和细菌的吞噬。细菌蛋白酶对这些细胞激活因子受体的破坏可能会消除这些(即补体衍生的)和其他介质执行其抗菌作用的能力,从而限制宿主对感染细菌的防御机制。细菌蛋白酶在细胞受体水平发挥作用,有效消除损伤部位的抗菌反应(即氧自由基产生和吞噬作用)这一概念尚未得到详细研究。在这种情况下,情况尤其特殊,因为一旦细菌牙龈蛋白酶产生强大的血浆衍生炎症因子,可增强水肿并为细菌提供必需营养,其他细菌蛋白酶可能会破坏它们的细胞受体。这些受体在浸润细胞中传递引发细菌杀伤的信号激活机制。(摘要截选)